Is the Initial Size of Tuberculous Lymphadenopathy associated with Lymph Node Enlargement during Treatment?
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seol, Yun Jae | - |
dc.contributor.author | Park, Se Yoon | - |
dc.contributor.author | Yu, Shi Nae | - |
dc.contributor.author | Kim, Tark | - |
dc.contributor.author | Lee, Eun Jung | - |
dc.contributor.author | Jeon, Min Huok | - |
dc.contributor.author | Choo, Eun Ju | - |
dc.contributor.author | Kim, Tae Hyong | - |
dc.date.accessioned | 2021-08-11T14:44:23Z | - |
dc.date.available | 2021-08-11T14:44:23Z | - |
dc.date.issued | 2017-06 | - |
dc.identifier.issn | 2093-2340 | - |
dc.identifier.issn | 2092-6448 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/7533 | - |
dc.description.abstract | There are little data on the changes in lymph node (LN) size during the treatment of tuberculous lymphadenopathy (TB LAP). This study aimed to provide data on LN changes during treatment. Between March 2014 and December 2015, 20 patients who were diagnosed with cervical TB LAP were enrolled. LN enlargement within two months (50%, 4/8 vs. 8.3%, 1/12; P = 0.04) was more frequently observed in patients with initial LN size >= 7.5 cm(2). Enlarged LNs were excised in three patients owing to pain and fistula formation. Initial LN size may be associated with LN enlargement during treatment. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy | - |
dc.title | Is the Initial Size of Tuberculous Lymphadenopathy associated with Lymph Node Enlargement during Treatment? | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3947/ic.2017.49.2.130 | - |
dc.identifier.scopusid | 2-s2.0-85021734271 | - |
dc.identifier.wosid | 000412491200006 | - |
dc.identifier.bibliographicCitation | Infection and Chemotherapy, v.49, no.2, pp 130 - 134 | - |
dc.citation.title | Infection and Chemotherapy | - |
dc.citation.volume | 49 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 130 | - |
dc.citation.endPage | 134 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002242025 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.subject.keywordPlus | LYMPHADENITIS | - |
dc.subject.keywordAuthor | Tuberculosis | - |
dc.subject.keywordAuthor | Lymphadenopathy | - |
dc.subject.keywordAuthor | Outcome | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.